hepatitis-c-virus

Documents about hepatitis-c-virus

• Barriers and facilitators to hepatitis C patient engagement: Interview study with general practitioner champions in England#358738PLOS
• Hepatitis C distribution across diverse population groups in the Eastern Mediterranean Region: An umbrella review#121530PLOS
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#141265PLOS
• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• Direct-acting antiviral therapy is associated with a reduced risk of selected immune-mediated inflammatory diseases in chronic hepatitis C infection: A real-world cohort study#313063PLOS
• Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2#826060ClinicalTrials.gov
• A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects#874039ClinicalTrials.gov
• CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects#904682ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection#995214ClinicalTrials.gov
• Cellular immune signatures of clinical outcome in hepatitis C virus infection#1005594The University of Melbourne Library Digital Repository
• Combating Related Epidemics in HCV#881744ClinicalTrials.gov
• A novel dimerization site in non-structural protein 5A of hepatitis C virus regulates viral replication fitness#431417PLOS
• Screening, Treatment, and Eradication of Hep C#852810ClinicalTrials.gov
• A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname#219392PLOS
• Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs#978859ClinicalTrials.gov
• Study of a Novel Therapeutic Vaccine for Hepatitis C Virus#208253ClinicalTrials.gov
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy#831606ClinicalTrials.gov
• ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection#807266ClinicalTrials.gov
• A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers#918189ClinicalTrials.gov
• Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection#838025ClinicalTrials.gov
• Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV#872747ClinicalTrials.gov
• Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography#849147ClinicalTrials.gov
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection#829671ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection#832873ClinicalTrials.gov
• Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus#912645ClinicalTrials.gov
• Hepatitis C Rimantadine and Antiviral Combination Therapy#888313ClinicalTrials.gov
• A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)#125946ClinicalTrials.gov
• Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?#918629ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment#891720ClinicalTrials.gov
• Recommendations and guidance on hepatitis C virus self-testing: web annex F: cost-effectiveness of hepatitis C virus self-testing#404861WHO IRIS
• A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection#846448ClinicalTrials.gov
• A data-driven approach to hepatitis C forecasting using machine learning and epidemiological models#626369PLOS
• Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)#849415ClinicalTrials.gov
• Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)#882641ClinicalTrials.gov
• Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection#910563ClinicalTrials.gov
• Genotype and Subtype Mapping of the Hepatitis C Virus#856997ClinicalTrials.gov
• Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection#859735ClinicalTrials.gov
• CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS#863206ClinicalTrials.gov
• An Observational Study of Hepatitis C Virus in Pregnancy#127780ClinicalTrials.gov
• Immune Response to Hepatitis C Virus#914292ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis#857029ClinicalTrials.gov
• NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection#858148ClinicalTrials.gov
• Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir#883389ClinicalTrials.gov
• A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients#853326ClinicalTrials.gov
• Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men#839285ClinicalTrials.gov
• Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia#859857ClinicalTrials.gov
• DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection#154726ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis#982052ClinicalTrials.gov
• Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients#862071ClinicalTrials.gov